Overview
Yangkai Li practices practicing medicine in Wuhan, China.
Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pectus Carinatum, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 34 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yangkai Li
Is Yangkai Li a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yangkai Li is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yangkai Li participate in research or clinical trials?
Yes. Yangkai Li has published 34 articles and abstracts on conditions like Lung Cancer. You can view a list of Yangkai Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaLi isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerLi isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Pectus CarinatumLi isExperienced. Learn about Pectus Carinatum.
- Pectus ExcavatumLi isExperienced. Learn about Pectus Excavatum.
- Small Cell Lung Cancer (SCLC)